作者:
Garcia,J.A. [1]
;
Hudes,G.R. [2]
;
Choueiri,T.K. [3]
;
Stadler,W.M. [4]
;
Wood,L.S. [5]
;
Gurtler,J. [6]
;
Bhatia,S. [7]
;
Joshi,A. [8]
;
Hozak,R.R. ;
Xu,Y. ;
Schwartz,J.D. ;
Thompson,J.A.
作者单位:
Metarie Oncology, Metairie LA, United States
[1]
Departments of Solid Tumor Oncology and Urology, Cleveland Clinic Taussig Cancer Institute, CCF
[2]
Dana-Farber Cancer Institute, Harvard Medical School, Boston MA, United States
[3]
Seattle Cancer Care Alliance, Seattle WA, United States, Fred Hutchinson Cancer Research Center
[4]
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia PA, United States
[5]
Eli Lilly and Company, Indianapolis IN, United States
[6]
ImClone Systems Inc., Branchburg NJ, United States
[7]
Hematology/Oncology Section, University of Chicago, Chicago IL, United States
[8]
发布时间
2018-07-27